Showing results (1551-1560 of 1,598) with videos related to
Sort By:
Pageof 160
Cancer Journal (Sudbury, Mass.)|August 1, 2012
Genetic testing by cancer site: pancreasJennifer E Axilbund, Elizabeth A WileyCancer Journal (Sudbury, Mass.)|July 26, 2022
Natural Killer Cell Recognition and Control of Epithelial CancersMarcelo de Souza Fernandez Pereira, David R Carr, Margaret E Gatti-Mays, et al.Cancer Journal (Sudbury, Mass.)|July 26, 2022
Current State of Cell Therapies for Breast CancerNamrata Gautam, Kelly M Elleson, Ganesan Ramamoorthi, et al.Cancer Journal (Sudbury, Mass.)|September 22, 2021
From VAD to VRD: Is Transplant Still Needed in the Upfront Setting of Myeloma?Harsh Parmar, David H Vesole, Noa BiranCancer Journal (Sudbury, Mass.)|September 22, 2021
Strategies to Overcome High-Risk Multiple MyelomaLarysa SanchezCancer Journal (Sudbury, Mass.)|September 22, 2021
Chimeric Antigen Receptor T-Cell Therapeutics for Multiple Myeloma: Moving Into the SpotlightBo Wang, Sridevi Rajeeve, Deepu MadduriCancer Journal (Sudbury, Mass.)|January 24, 2022
Menin Inhibitors in Acute Myeloid Leukemia-What Does the Future Hold?Mahesh Swaminathan, Wallace Bourgeois, Scott A Armstrong, et al.Cancer Journal (Sudbury, Mass.)|January 24, 2022
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia: How Should We Use Currently Available Agents?Tapan M Kadia, Andrew H WeiCancer Journal (Sudbury, Mass.)|August 18, 2018
Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid TumorsFlorence Koeppel, Alexandre Bobard, Céline Lefebvre, et al.Cancer Journal (Sudbury, Mass.)|August 18, 2018
Bevacizumab and Glioblastoma: Past, Present, and Future DirectionsMichelle M Kim, Yoshie Umemura, Denise LeungPageof 160